![Christopher Waddick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Waddick
Financieel Directeur/CFO bij
CARDIOL THERAPEUTICS INC.
Vermogen: 165 798 $ op 31-05-2026
Profiel
Mr. Christopher J.
Waddick is a Chief Financial Officer, Secretary & Director at Cardiol Therapeutics, Inc., a President & Chief Financial Officer at Active Energy, Inc. and a President at Nrj Consulting, Inc. He is on the Board of Directors at Cardiol Therapeutics, Inc. Mr. Waddick was previously employed as a Chief Financial & Executive Officer by Vasogen, Inc. He received his undergraduate degree from Wilfrid Laurier University and an MBA from York University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-12-2025 | 135.900 ( 0,12% ) | 165 798 $ | 31-05-2026 |
Actieve functies van Christopher Waddick
| Bedrijven | Functie | Begin |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Financieel Directeur/CFO | 16-08-2018 |
Active Energy, Inc.
 Active Energy, Inc. Electric UtilitiesUtilities Supplies natural gas and electricity | Financieel Directeur/CFO | 01-01-2013 |
Nrj Consulting, Inc. | President | 01-11-2009 |
Eerdere bekende functies van Christopher Waddick
| Bedrijven | Functie | Einde |
|---|---|---|
Vasogen, Inc.
 Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Algemeen Directeur | - |
Opleiding van Christopher Waddick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Health Technology |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wilfrid Laurier University
 Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Active Energy, Inc.
Active Energy, Inc. Electric UtilitiesUtilities Supplies natural gas and electricity | Utilities |
Cardiol Therapeutics, Inc.
 Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease | Health Technology |
Nrj Consulting, Inc. |
